NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse Model

EBioMedicine

Volumn 21, Issue , 2017, Pages 3-4

  Nadon, Nancy L ^a   Strong, Randy ^b   Miller, Richard A ^c   Harrison, David E ^d  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; ACARBOSE; ACETYLSALICYLIC ACID; NORDIHYDROGUAIARETIC ACID; RAPAMYCIN;

AGING; CALORIC RESTRICTION; FOOD PROCESSING; GENETICALLY ENGINEERED MOUSE STRAIN; INTERVENTIONS TESTING PROGRAM; LIFE EXTENSION; MEDICAL RESEARCH; MICROENCAPSULATION; NONHUMAN; NOTE; PILOT STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; ANIMAL; DRUG EFFECT; FEMALE; GENETICS; GENOTYPE; MALE; MOUSE; PHARMACOGENETICS; PRECLINICAL STUDY; PROCEDURES; STANDARDS;

AGING; ANIMALS; DRUG EVALUATION, PRECLINICAL; FEMALE; GENOTYPE; MALE; MICE; PHARMACOGENETICS;

EID: 85007496719     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.11.038     Document Type: Note

References (10)

1. Flurkey, K., Astle, C.M., Harrison, D.E., Life extension by diet restriction and N-acetyl-L-cysteine in genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 65 (2010), 1275–1284.
2. Harrison, D.E., Strong, R., Sharp, Z.D., Nelson, J.F., Astle, C.M., Flurkey, K., Nadon, N.L., Wilkinson, J.E., Frenkel, K., Carter, C.S., Pahor, M., Javors, M.A., Fernandez, E., Miller, R.A., Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460 (2009), 392–395.
3. Harrison, D.E., Strong, R., Allison, D.B., Ames, B.N., Astle, C.M., Atamna, H., Fernandez, E., Flurkey, K., Javors, M.A., Nadon, N.L., Nelson, J.F., Simpkins, J.W., Smith, D., Wilkinson, J.E., Miller, R.A., Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell 13 (2014), 273–282.
4. Miller, R.A., Harrison, D., Astle, C.M., Baur, J.A., deCabo, R., Fernandez, E., Flurkey, K., Javors, M.A., Nelson, J.F., Pletcher, S., Sharp, Z.D., Sinclair, D., Starnes, J.W., Wilkinson, J.E., Nadon, N.L., Strong, R., Rapamycin, but not resveratrol or simvastatin, extends lifespan of genetically heterogeneous mice. J. Gerontology, Biol. Sci. 66A (2011), 191–201.
5. Miller, R.A., Harrison, D.E., Astle, C.M., Fernandez, E., Flurkey, K., Han, M., Javors, M.A., Li, X., Nadon, N.L., Nelson, J.F., Pletcher, S., Salmon, A.B., Sharp, Z.D., Van Roekel, S., Winkleman, L., Strong, R., Rapamycin-mediated lifespan increase in mice is dose and sex-dependent and metabolically distinct from dietary restriction. Aging Cell 13 (2014), 468–477.
6. Nadon, N.L., Strong, R., Miller, R.A., Nelson, J., Javors, M., Sharp, Z.D., Peralba, J.M., Harrison, D.E., Design of aging intervention studies: the NIA interventions testing program. Age 30 (2008), 187–199.
7. Nadon, N.L., Miller, R.A., Strong, R., Harrison, D.E., NIA interventions testing program: a collaborative approach for investigating interventions to promote healthy aging. Kaeberlein, M.R., Martin, G.M., (eds.) Handbook for the Biology of Aging, eighth ed., 2015, 287–303.
8. Strong, R., Miller, R.A., Astle, C.M., Floyd, R.A., Flurkey, K., Hensley, K.L., Javors, M.A., Leeuwenburgh, C., Nelson, J.F., Ongini, E., Nadon, N.L., Warner, H.R., Harrison, D.E., Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 7 (2008), 641–650.
9. Strong, R., Miller, R.A., Astle, C.M., Baur, J.A., de Cabo, R., Fernandez, E., Guo, W., Javors, M., Kirkland, J.L., Nelson, J.F., Sinclair, D., Teter, B., Williams, D., Zaveri, N., Nadon, N.L., Harrison, D.E., Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium chain triglyceride oil on lifespan of genetically heterogeneous mice. J. Gerontol. Biol. Sci. 68 (2012), 6–16.
10. Strong, R., Miller, R.A., Antebi, A., Astle, C.M., Bogue, M., Denzel, M.S., Fernandez, E., Flurkey, K., Hamilton, K.L., Lamming, D.W., Javors, M.A., de Magalhães, J.P., McCord, J.M., Miller, B.F., Müller, M., Nelson, J.F., Ndukum, J., Rainger, G.E., Richardson, A., Sabatini, D.M., Salmon, A.B., Simpkins, J.W., Steegenga, W.T., Nadon, N.L., Harrison, D.E., Longer lifespan in male mice treated with a weakly-estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. Aging Cell, 2016, 10.1111/acel.12496.